T1	p 25 43	prostatic cancer .
T2	p 162 222	previously untreated patients with prostatic cancer in order
T3	p 234 237	low
T4	p 623 696	patients with advanced disease no longer responsive to hormonal treatment
T5	i 238 317	dose Stilboestrol versus Cyproterone acetate versus Medroxyprogesterone acetate
T6	i 343 355	Stilboestrol
T7	i 363 371	Estracyt
T8	i 473 485	Stilboestrol
T9	i 586 599	gynaecomastia
T10	i 723 751	Adriamycin or Procarbazine .
T11	o 752 776	Toxicity and early death